Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Cash from Operations (2022 - 2025)

Historic Cash from Operations for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$1.4 million.

  • Neuraxis' Cash from Operations fell 249.4% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.3 million, marking a year-over-year increase of 1022.73%. This contributed to the annual value of -$6.1 million for FY2024, which is 889.93% up from last year.
  • Per Neuraxis' latest filing, its Cash from Operations stood at -$1.4 million for Q3 2025, which was down 249.4% from -$1.5 million recorded in Q2 2025.
  • Over the past 5 years, Neuraxis' Cash from Operations peaked at -$214315.0 during Q4 2022, and registered a low of -$2.8 million during Q3 2023.
  • In the last 4 years, Neuraxis' Cash from Operations had a median value of -$1.4 million in 2025 and averaged -$1.4 million.
  • In the last 5 years, Neuraxis' Cash from Operations tumbled by 112695.98% in 2023 and then skyrocketed by 5054.47% in 2024.
  • Neuraxis' Cash from Operations (Quarter) stood at -$214315.0 in 2022, then tumbled by 1126.96% to -$2.6 million in 2023, then soared by 33.14% to -$1.8 million in 2024, then grew by 18.81% to -$1.4 million in 2025.
  • Its Cash from Operations was -$1.4 million in Q3 2025, compared to -$1.5 million in Q2 2025 and -$1.6 million in Q1 2025.